Selumetinib Clinical Trials
3 recruitingDrug
Phase 12Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 2
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Neurofibromatosis 1Plexiform Neurofibroma
University of Alabama at Birmingham200 enrolled13 locationsNCT06188741
Recruiting
Phase 1Phase 2
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Pediatric Cancer
Gustave Roussy, Cancer Campus, Grand Paris472 enrolled21 locationsNCT02813135
Recruiting
Phase 1
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Chronic Myeloid LeukemiaMyelofibroses
University of Chicago18 enrolled1 locationNCT03326310